Sequencing SARS-CoV-2 from Antigen Tests

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Feb 8

PMID 35134077

Authors

Ashley Nazario-Toole

Holly M Nguyen

Hui Xia

Dianne N Frankel

John W Kieffer

Thomas F Gibbons

Affiliations

Soon will be listed here.

Abstract

Genomic surveillance empowers agile responses to SARS-CoV-2 by enabling scientists and public health analysts to issue recommendations aimed at slowing transmission, prioritizing contact tracing, and building a robust genomic sequencing surveillance strategy. Since the start of the pandemic, real time RT-PCR diagnostic testing from upper respiratory specimens, such as nasopharyngeal (NP) swabs, has been the standard. Moreover, respiratory samples in viral transport media are the ideal specimen for SARS-CoV-2 whole-genome sequencing (WGS). In early 2021, many clinicians transitioned to antigen-based SARS-CoV-2 detection tests, which use anterior nasal swabs for SARS-CoV-2 antigen detection. Despite this shift in testing methods, the need for whole-genome sequence surveillance remains. Thus, we developed a workflow for whole-genome sequencing with antigen test-derived swabs as an input rather than nasopharyngeal swabs. In this study, we use excess clinical specimens processed using the BinaxNOW™ COVID-19 Ag Card. We demonstrate that whole-genome sequencing from antigen tests is feasible and yields similar results from RT-PCR-based assays utilizing a swab in viral transport media.

Citing Articles

Opportunities for Enhanced Public Health Surveillance via Molecular Detection and Sequencing of Diverse Respiratory Viruses From Self-collected SARS-CoV-2 Antigen Test Swabs.

Schmidt K, Pollett S, Richard S, Hogan V, Hone E, Rothenberg J Open Forum Infect Dis. 2024; 11(8):ofae447.

PMID: 39175525 PMC: 11339864. DOI: 10.1093/ofid/ofae447.

Optimisation and evaluation of viral genomic sequencing of SARS-CoV-2 rapid diagnostic tests: a laboratory and cohort-based study.

Paull J, Petros B, Brock-Fisher T, Jalbert S, Selser V, Messer K Lancet Microbe. 2024; 5(5):e468-e477.

PMID: 38621394 PMC: 11322816. DOI: 10.1016/S2666-5247(23)00399-3.

Wastewater surveillance in the COVID-19 post-emergency pandemic period: A promising approach to monitor and predict SARS-CoV-2 surges and evolution.

Jimenez B, Sterling T, Brown A, Modica B, Gibson K, Collins H Heliyon. 2023; 9(11):e22356.

PMID: 38045160 PMC: 10689941. DOI: 10.1016/j.heliyon.2023.e22356.

Challenges of SARS-CoV-2 genomic surveillance in India during low positivity rate scenario.

Tomar S, Khairnar K Front Public Health. 2023; 11:1117602.

PMID: 37441634 PMC: 10335399. DOI: 10.3389/fpubh.2023.1117602.

Adequacy of using a single nasal swab for rapid influenza diagnostic testing, PCR, and whole genome sequencing.

Temte J, Bell C, Goss M, Reisdorf E, Tamerius J, Reddy S PLOS Glob Public Health. 2023; 3(5):e0001422.

PMID: 37224148 PMC: 10208452. DOI: 10.1371/journal.pgph.0001422.

References

Tillett R, Sevinsky J, Hartley P, Kerwin H, Crawford N, Gorzalski A . Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2020; 21(1):52-58. PMC: 7550103. DOI: 10.1016/S1473-3099(20)30764-7. View

Long S, Olsen R, Christensen P, Subedi S, Olson R, Davis J . Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern. Am J Pathol. 2021; 191(6):983-992. PMC: 7962948. DOI: 10.1016/j.ajpath.2021.03.004. View

Li X, Wang W, Zhao X, Zai J, Zhao Q, Li Y . Transmission dynamics and evolutionary history of 2019-nCoV. J Med Virol. 2020; 92(5):501-511. PMC: 7166881. DOI: 10.1002/jmv.25701. View

Coughlin S, Yiiter A, Xu H, Berman A, Chen J . Early detection of change patterns in COVID-19 incidence and the implementation of public health policies: A multi-national study. Public Health Pract (Oxf). 2021; 2:100064. PMC: 7754913. DOI: 10.1016/j.puhip.2020.100064. View

Shu Y, McCauley J . GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017; 22(13). PMC: 5388101. DOI: 10.2807/1560-7917.ES.2017.22.13.30494. View

Cyranoski D . Alarming COVID variants show vital role of genomic surveillance. Nature. 2021; 589(7842):337-338. DOI: 10.1038/d41586-021-00065-4. View

Marcus J, Frankel D, Pawlak M, Casey T, Blackwell R, Tran F . COVID-19 Monitoring and Response Among U.S. Air Force Basic Military Trainees - Texas, March-April 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(22):685-688. PMC: 7315849. DOI: 10.15585/mmwr.mm6922e2. View

Mutnal M, Johnson S, Mohamed N, Abddelgader R, Morales L, Volz M . Surveillance genome sequencing reveals multiple SARS-CoV-2 variants circulating in central Texas, USA, with a predominance of delta variant and review of vaccine breakthrough cases. J Med Virol. 2021; 94(3):937-944. PMC: 8661622. DOI: 10.1002/jmv.27373. View

Nazario-Toole A, Xia H, Gibbons T . Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution. Mil Med. 2021; 187(1-2):e130-e137. PMC: 7928784. DOI: 10.1093/milmed/usab031. View

10.

Lippi G, Simundic A, Plebani M . Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020; 58(7):1070-1076. DOI: 10.1515/cclm-2020-0285. View

11.

Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View

12.

Oude Munnink B, Worp N, Nieuwenhuijse D, Sikkema R, Haagmans B, Fouchier R . The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology. Nat Med. 2021; 27(9):1518-1524. DOI: 10.1038/s41591-021-01472-w. View

13.

Ito Y . Clinical Diagnosis of Influenza. Methods Mol Biol. 2018; 1836:23-31. DOI: 10.1007/978-1-4939-8678-1_2. View

14.

Chiara M, DErchia A, Gissi C, Manzari C, Parisi A, Resta N . Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities. Brief Bioinform. 2020; 22(2):616-630. PMC: 7799330. DOI: 10.1093/bib/bbaa297. View